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ABSTRACT
In an immune system, dendritic cells (DCs) are professional antigen-presenting cells (APCs) as well as power-
ful sensors of danger signals. When DCs receive signals from infection and tissue stress, they immediately ac-
tivate and instruct the initiation of appropriate immune responses to T cells. However, it has remained unclear
how the tissue microenvironment in a steady state shapes the function of DCs. Recent many works on thymic
stromal lymphopoietin (TSLP), an epithelial cell-derived cytokine that has the strong ability to activate DCs, pro-
vide evidence that TSLP mediates crosstalk between epithelial cells and DCs, involving in DC-mediated im-
mune homeostasis. Here, we review recent progress made on how TSLP expressed within the thymus and pe-
ripheral lymphoid and non-lymphoid tissues regulates DC-mediated T-cell development in the thymus and T-
cell homeostasis in the periphery.
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INTRODUCTION
TSLP is an interleukin (IL)-7-like cytokine that was
cloned from murine thymic stromal cell line.1-3 TSLP
is expressed mainly by epithelial cells at barrier sur-
faces and is capable of initiating a wide variety of re-
sponses in many cell types, particularly myeloid DCs.
The TSLP receptor (TSLPR) complex consists of a
heterodimer of the IL-7 receptor α chain (IL-7Rα)
and TSLPR.4-7 In humans, TSLPR is highly expressed
by myeloid DCs (mDCs), and TSLP produced by epi-
thelial cells strongly activates mDCs to upregulate
MHC class II and co-stimulatory molecules, improve
survival, and produce a variety of chemokines, such
as CCL-17 (TARC) and CCL-21 (MDC). Interestingly,
unlike other signals that activate mDCs such as the
ligand for TLR3 or TLR4, TSLP does not induce
mDCs to produce proinflammatory cytokines IL-12,
IL-6, TNF-α, and IL-1.8 Epithelial cells in the tissue
microenvironment appear to play a key role in in-
structing the tissue-resident DCs to control immune
responses and homeostasis. However, it has been un-
clear how DCs regulate immune homeostasis at the
steady state and during disease.
TSLP AND THYMIC SELECTION OF REGU-
LATORY T (TREG) CELLS
TREG CELL DEVELOPMENT IN THYMUS
While majority of hematopoietic cells develop in the
bone marrow, bone marrow-derived T cell progeni-
tors migrate into the thymus and complete their de-
velopment in the thymus. It has been generally ac-
cepted that when developing T cells express a T cell
antigen receptor (TCR), they undergo two different
types of selection based on the binding affinity of the
TCR to a self-peptide-MHC complex presented by
thymic epithelial cells or dendritic cells. First, devel-
oping T cells express a functional TCR that binds to a
self-peptide-MHC class I or class II complex, which is
presented by epithelial cells in the thymic cortex,
then they undergo a process known as positive selec-
tion.9-11 While the developing T cells that fail positive
selection die by apoptosis, the positively selected T
cells survive and migrate into the medullar area of
the thymus. These T cell precursors undergo a proc-
ess of negative selection by which T cells carrying a
TCR with high-affinity for a self-peptide-MHC com-
plex expressed by APCs in the thymic medulla. How-
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Fig.　1　Hassall’s corpuscles express TSLP. a. Epithelial 
cells in Hassall’s corpuscles express TSLP (red). b. TSLP-
expressed HCs (red) co-localize with DC-LAMP+ activated 
DCs (blue) in the medulla of the human thymus (Original 
magnifi cations, a: ×400, b: ×200).
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ever, some self-reactive T cells escape into the pe-
riphery and could cause autoimmunity. It is now well
established that these self-reactive T cells are con-
trolled in the periphery by CD4+Foxp3+ Treg cells
that developed in the thymus.12-14 The importance of
Treg-mediated tolerance is illustrated by the observa-
tion that the acute elimination of Foxp3+ Treg cells in
normal healthy animals can lead to death owing to
multi-organ autoimmune disease.15,16 However, it is
unclear what type of APCs positively selects Treg
cells in the thymus and how these self-reactive Treg
cells escape selection mediated by thymic APCs.
Although it was initially reported that Treg cell de-
velopment starts at the CD4+CD8+ (DP) stage,17,18
more recent studies suggest that most Treg cells de-
velop after positively selected CD4+ thymocytes mi-
grate from the cortex to the medulla, which is com-
prised of medullary thymic epithelial cells (mTECs)
and hematopoietic DCs.19-21 Pioneering studies using
mouse models suggest that thymic epithelial cells are
crucial for the induction of non-deletional tolerance
by generating Treg cells. Mouse chimeras in which
bone marrow-derived APCs were deficient in MHC
class II showed normal numbers of thymic Treg
cells,18,22 suggesting that mTECs may be crucial for
Treg cell development. However in TCR-transgenic
systems, the expression of cognate antigens on either
epithelial cells or DCs seemed to be able to induce
Treg development.23,24 We and other groups recently
found that the expression of CD80CD86 and CD40,
which are key co-stimulatory molecules for Treg cell
development, on only DCs subsets was also sufficient
to generate a normal percentage of Treg cells.25-27
Moreover, normal or elevated numbers of Treg cells
were observed when MHC class II presentation was
decreased on AIRE+ mTECs,28 supporting the notion
that either mTECs or DCs are sufficient for Treg cell
development in the thymic medulla. These studies
conclude that both mTECs and hematopoietic DCs
can facilitate Treg cell development. However, it is
still unclear 1) how DCs can have a positive role in
the selection of self-reactive Treg cells as well as a
negative role in the deletion of high-affinity self-
reactive thymocytes and, 2) why multiple APCs are
involved in generating Treg cells in the thymus. Our
findings may give answer to these questions.
TSLP EXPRESSED BY HASSAL’S CORPUSCLES
INSTRUCTS DCs TO SELECT TREG IN HUMAN
THYMUS.
Corpuscular bodies of epithelial cells called Hassall’s
corpuscles (HCs) are located in the medulla of the
human thymus. After the first description by Arthur
Hill Hassall in 1849, it was suggested that HCs repre-
sent the “graveyard” for dead thymocytes29,30 and the
“privileged” area for the maturation of medullary thy-
mocytes.31 Other studies have provided evidence that
HCs are active in cytokinegrowth factor receptor-
mediated cell signaling, transcription and metabo-
lism.32-37 Although HCs have been proposed to act in
both the removal of apoptotic thymocytes and the
maturation of developing thymocytes in the thymus,
their actual function has remained unclear. We found
that TSLP is selectively expressed by epithelial cells
of HCs within the human thymic medulla (Fig. 1a).38
TSLP appears to activate DCs isolated from human
thymus, and anatomical analysis by immune histo-
chemistry showed that TSLP expression is associated
with an activated subpopulation of mDCs in the thy-
mic medulla (Fig. 1b). Because the thymus is nor-
mally not exposed to microbial infections, this raised
a question regarding the functions of TSLP and
TSLP-activated DCs in the thymus. It has been pro-
posed that TSLP-activated mDCs may play an impor-
tant role in the selection of self-reactive thymocytes
to differentiate into Treg cells because TSLP-mDCs
have 1) high expression levels of MHC class-II and
the costimulatory molecules CD80CD86, which are
ligands for CD28 and are critical for Treg cell devel-
opment in the medulla of the human thymus,39,40 2)
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Fig.　2　TSLPR+ pDCs co-localize with FOXP3+ Treg in human thymus. a. Phenotype of pDCs en-
riched from total human thymocytes. b. Subpopulation of thymic pDCs expresses TSLPR at the 
steady state. c. Double immunofl uorescence staining of FOXP3 (green) and CD123 (red) was 
performed on human thymus. Thymic pDCs co-localize with FOXP3+ cells in the thymic medulla 
(Magnifi cation: ×40)
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sparse production of proinflammatory cytokines such
as IL-1, IL-6, and IL-12, which inhibit Treg cell devel-
opment; and 3) the ability to induce robust homeo-
static proliferation of naïve CD4+ T cells owing to
their unique ability to form strong and prolonged con-
jugates with autologous CD4+ T cells.41 Therefore,
TSLP-activated DCs may use the same mechanisms
to provide strong and long-lasting survival signals to
self-reactive thymocytes and switch negative selec-
tion to a positive selection of Treg cell development.
This hypothesis is supported by our experiments
showing that TSLP-activated DCs, but not DCs stimu-
lated with or without IL-7, CD40 ligands or poly (I:
C), could induce the expansion and differentiation of
CD4+CD8−CD25− SP thymocytes into CD4+CD8−
CD25+FOXP3+ Treg cells.38 The ability of TSLP-
activated DCs to induce Treg cell differentiation was
dependent on IL-2 and CD28 signals. Anatomically,
CD4+CD25+ thymocytes are exclusively located in the
thymic medulla in close association with DC-LAMP+
CD86+-activated DCs and HCs. These results suggest
that human Treg cells are generated in the thymic
medulla in close association with DCs that seem to be
activated by TSLP, which is produced by epithelial
cells of HCs.
The human thymus contains three distinct popula-
tions of DCs including plasmacytoid DCs (pDCs) and
two subsets of conventional myeloid DCs (cDCs),
CD11c+CD11b− and the CD11c+CD11b+.42,43 We re-
cently found that a subpopulation of pDCs (~20%) iso-
lated from the human thymus also expressed the
TSLP receptor (TSLPR) at the steady state (Fig. 2a,
b).44 This pDC subpopulation is located in close asso-
ciation with FOXP3+ T cells in the thymic medulla. In
vitro, TSLP conditioned pDCs to produce the
chemokines CCL-17 (TARC) and CCL-21 (MDC),
which are important in guiding the traffic of imma-
ture thymic T cells into the medulla. Furthermore,
the TSLP-conditioned pDCs could efficiently induce
the generation and expansion of CD4+CD25+FOXP3+
Treg cells from CD4+CD25−FOXP3− thymocytes but
not peripheral naïve CD4+ T cells in vitro. Interest-
ingly, the TSLP-pDC-induced Treg cells were IL-
10highTGF-βlow while the TSLP-mDC-induced Treg
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cells were IL-10lowTGF-βhigh after activation, sug-
gesting that multiple types of APCs in the thymus,
such as TSLP-mDCs and TSLP-pDCs, are responsible
for the imprinting of functionally distinct subsets of
FOXP3+ Treg cells. These data are consistent with
our recent observation that the human thymus, pe-
ripheral blood, and secondary lymphoid tissues con-
tain two subsets of CD25+FOXP3+ Treg cells based
on expression of ICOS and production of IL-10TGF-
β.45 Differentiation of T cells into distinct cell lineages
is controlled by several key transcriptional factors
that have pivotal roles in determining cell fate during
the early stage of lymphoid cell development. These
lineage specification factors not only promote a par-
ticular T cell fate, but they are also responsible for re-
pressing alternative differentiation pathways. In our
experiments, IL-12 and IL-4, which are critical for pro-
moting Th1 or Th2 differentiation, respectively, and
proinflammatory cytokines actively repress the fate of
CD4+ thymocytes to differentiate into Treg cells, sug-
gesting that the transcriptional factors induced by
these cytokines override FOXP3-dependent genera-
tion of Treg cells. Both TSLP-mDCs and TSLP-pDCs
produce low levels of Th1-promoting cytokines and
proinflammatory cytokines. This sterileaseptic way
to activate DCs by TSLP may explain a unique feature
that is likely to be essential for the differentiation of
FOXP3+ Treg cells in the thymic microenvironment.
Although the existence of a unique niche in the thy-
mus has been proposed, its exact nature has re-
mained unclear.22,46 Decoding the molecular signa-
ture of DCs, including surface molecules and soluble
factors, such as cytokines, that positively or nega-
tively regulate thymic selection, should be accom-
plished in order to determine mechanisms of Treg
differentiation in the thymus. Thus, we speculate that
Treg differentiation in the thymus is regulated in a
very subtle way by DCs, providing a suitable niche
that allows Treg cells to develop.
In mice, several studies showed that mouse TSLP
strongly promotes the differentiation and expansion
of Foxp3+ Treg cells in the thymus and periphery.47-49
In fetal thymus organ culture (FTOC) model, mouse
TSLP increases expression of Foxp3 as well as Treg.
The expression of Foxp3 is inhibited by blocking
TSLP.48 A striking reduction of Treg is observed in
IL-7Rα-- mice. However, mice deficient in IL-7 or
TSLPR do not exhibit any differences in Treg devel-
opment, and combined deletion of IL-7 and TSLPR
greatly reduced Treg development in the thymus,
suggesting Treg cells require signals from the IL-7R,
but require partially overlapping actions of both IL-7
and TSLP for development of Treg cells in mice.50
The difference in human and mice may be due to spe-
cies differences, as Hassall’s corpuscle is well devel-
oped in the human thymus but poorly in mice.
TSLP IN PERIPHERAL CD4+ T CELL HO-
MEOSTASIS
T cell homeostasis is a self-regulating process for
maintaining the overall size and TCR repertoire of the
pool of mature peripheral T cells. This process is es-
sential for enabling the adaptive immune system to
respond to a variety of new pathogens and for main-
taining immunological memory to previously encoun-
tered pathogens.51 T cell homeostasis contributes to
the recovery of the peripheral T cell pool after T cell
deletion caused by certain viral infections, chemo-
therapy and radiation treatment.52 It can also main-
tain peripheral T cell numbers throughout life when
production of new naïve T cells has been reduced be-
cause of an atrophic thymus. In mice, T cell homeo-
stasis is maintained by T cell survival and expansion
triggered by self-antigen and cytokines. Survival and
homeostatic expansion of naïve CD4+ and CD8+ T
cells requires the interaction between the TCR and
self-peptide-MHC complex along with IL-7.51-55 Mem-
ory CD4+ T cell homeostasis is regulated by IL-7 and
TCR signals, whereas memory CD8+ T cell homeosta-
sis depends on IL-15 andor IL-7.51-56 In humans, the
memory CD4+ T cell population consists of central
memory T cells and an effector memory T cell sub-
set.57 Central memory CD4+ T cells express CCR7
and CD62L, which are homing receptors to secon-
dary lymphoid organs, and lack immediate effector
function. Effector memory T cells express receptors
that permit migration into inflamed tissues and show
immediate effector function. Effector memory CD4+ T
cells proliferate in response to the combination of IL-
7 and IL-15.58 In contrast, naïve CD4+ T cells and cen-
tral memory CD4+ T cells do not proliferate in re-
sponse to IL-7 and IL-15. Although monocyte-derived
mature DCs endow naïve CD4+ T cells with the ca-
pacity to respond to IL-7 and IL-15, this combination
facilitates differentiation of central memory CD4+ T
cells into effector memory T cells.58
Thus, requirements for homeostatic proliferation of
human naïve and central memory CD4+ T cells are
still unclear. Because human TSLP-DCs induce very
strong antigen-specific expansion of naïve CD4+ T
cells,8 we hypothesize that human TSLP-DCs support
T cell homeostasis by promoting autologous CD4+ T
cell proliferation in the absence of foreign antigens.
We found that TSLP is expressed by crypt epithe-
lial cells of human tonsils, and that its expression is
closely associated with DC-LAMP+-activated DCs un-
der normal physiological conditions (Fig. 3).41 Be-
cause TSLP-activated DCs have the capacity to in-
duce very strong expansion of naïve CD4+ T cells, we
hypothesize that human TSLP expressed by the epi-
thelial cells of peripheral mucosa lymphoid tissues
may play a critical role in DC-mediated homeostatic
proliferation of naïve and memory T cells. Indeed, we
found that only TSLP-activated mDCs, but not resting
TSLP and Immune Homeostasis
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Fig.　3　Expression of TSLP in human tonsillar epithelial cells and its association with activated DCs. a-b. Dou-
ble staining of TSLP (red) and DC-LAMP (blue) shows expression of TSLP by crypt epithelial cells, which are in 
close association with DC-LAMP+ activated DCs (Original magnifi cations, a: ×100, b: ×200).
ba
or IL-7, CD40L, LPS, or poly (I:C)-activated mDCs,
could induce a robust and sustained expansion of au-
tologous naïve CD4+ T cells without any exogenous
antigens, cytokines, or fetal bovine serum. This
unique ability of TSLP-activated DCs correlated with
their strong capacity to form prolonged conjugates
with the autologous naïve CD4+ T cells, thus provid-
ing sustained proliferation and survival signals. The
expansion of autologous naïve CD4+ T cells induced
by TSLP-activated mDCs displayed features of ho-
meostatic expansion mediated by self-peptide-MHC
complexes, 1) it was dependent on MHC class II and
the costimulatory molecules CD80CD86, but not on
IL-7 or IL-15, 2) it was a polyclonal expansion as indi-
cated by TCR Vβ repertoire analysis and CFSE-
labeling experiments, and 3) the expanded T cells
displayed a central memory T cell phenotype
(CD45RO+CCR7+CD27+CD62L+) and had the poten-
tial to further expand and differentiate into either Th1
or Th2 effector cells.
Homeostatic proliferation of CRTH2+CD4+ memory
T cell is also supported by TSLP-activated autologous
DCs. After multiple rounds of stimulation with TSLP-
DCs, they maintain the central memory T cell pheno-
types and Th2 commitment.59 Under this condition,
OX40OX40L interaction between TSLP-DCs and
CRTH2+CD4+T cells, which sustained DC-T cell con-
jugate formation, contributes to longevity of both
DCs and T cells. The survival of T cells by OX40
OX40L was associated with the induction of Bcl-xL
and Bcl-2 expression.59-61
A recent study suggests that TSLP constitutively
produced by epithelial cell in the gut is critical to the
conditioning of mucosal DCs to have a non-
inflammatory phenotype and maintain mucosal ho-
meostasis.62-66 In support of this model, decreased
TSLP production was found to be associated with
Crohn’s disease.63 Further evidence for the involve-
ment of TSLP in maintaining gut homeostasis is the
finding that TSLPR-deficient mice showed a more
rapid onset and severity of disease in a commensal
bacteria-dependent mouse model of inflammatory
bowel disease,64 suggesting that one of the signals
that induces TSLP expression by epithelial cells may
be triggered by commensal bacteria.
SUMMARY
The major cell type responsive to TSLP is mDCs.
TSLP represents the only factor that activates mDCs
without inducing them to produce Th1- and proin-
flammatory cytokines. This sterileaseptic way of ac-
tivating mDCs is in contrast to the way TLR ligands
activate DCs, and may explain the uniqueness of
TSLP-DC function. Under normal physiological con-
ditions, human TSLP appears to play a critical role in
CD4+T cell homeostasis in the peripheral mucosa-
associated lymphoid tissues41,63 and in the positive
selection of Tregs in the thymus.38,44
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